Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1,385,160,313
-
Total 13F shares
-
54,801,174
-
Share change
-
+4,664,026
-
Total reported value
-
$15,693,904,741
-
Put/Call ratio
-
18%
-
Price per share
-
$286.44
-
Number of holders
-
233
-
Value change
-
+$1,342,169,395
-
Number of buys
-
148
-
Number of sells
-
65
Institutional Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q3 2020
As of 30 Sep 2020,
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) was held by
233 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,801,174 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Capital International Investors, HILLHOUSE CAPITAL ADVISORS, LTD., FMR LLC, PRIMECAP MANAGEMENT CO/CA/, Temasek Holdings (Private) Ltd, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, BAILLIE GIFFORD & CO, and BOXER CAPITAL, LLC.
This page lists
237
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.